Lido Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Sell
5,701
-6,171
-52% -$2.61M 0.01% 762
2026
Q1
$5.62M Buy
11,872
+3,713
+46% +$1.87M 0.02% 434
2025
Q4
$3.51M Buy
8,159
+335
+4% +$156K 0.01% 549
2025
Q3
$3.33M Buy
7,824
+1,221
+18% +$473K 0.01% 541
2025
Q2
$2.53M Sell
6,603
-563
-8% -$203K 0.01% 527
2025
Q1
$2.48M Buy
7,166
+142
+2% +$45.7K 0.01% 493
2024
Q4
$2.11M Sell
7,024
-1,491
-18% -$521K 0.01% 508
2024
Q3
$3.46M Buy
8,515
+139
+2% +$50.9K 0.02% 362
2024
Q2
$2.69M Buy
8,376
+4,617
+123% +$1.5M 0.02% 393
2024
Q1
$1.25M Buy
3,759
+1,130
+43% +$345K 0.01% 567
2023
Q4
$712K Buy
2,629
+106
+4% +$26.2K ﹤0.01% 731
2023
Q3
$621K Sell
2,523
-8,239
-77% -$2.25M ﹤0.01% 687
2023
Q2
$3.27M Buy
10,762
+9,235
+605% +$2.57M 0.02% 286
2023
Q1
$403K Buy
1,527
+390
+34% +$99.1K ﹤0.01% 762
2022
Q4
$273K Buy
+1,137
New +$255K ﹤0.01% 817

Other funds holding HCA

Lido Advisors's HCA Position: Q2 2026 in Review

Lido Advisors reduced its HCA Healthcare (HCA) stake by 52% in Q2 2026, selling an estimated $2.61M and leaving 5,701 shares worth $2.22M. The position accounts for 0.01% of the portfolio, ranked #762.

Lido Advisors first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.62M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Lido Advisors held 5,701 shares of HCA Healthcare worth $2.22M as of Q2 2026.
  • Lido Advisors sold 6,171 HCA Healthcare shares in Q2 2026, an estimated $2.61M.
  • HCA Healthcare made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #762 holding.
  • Lido Advisors first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Lido Advisors's HCA Healthcare position peaked at $5.62M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.